TCL Archive Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says December 15, 1995
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004